Sony’s latest LinkBuds, the Clip, are fine. They’re not the best sounding or lightest buds in their class, and their clip-on ...

The Sony Bravia 7 TV, while overshadowed by the flashier Bravia 9, is still a noteworthy option, especially for those seeking an affordable Sony mini-LED TV. We break down the pros and cons in this ...

Gather ‘round, it’s time to catch up on the latest batch of Engadget reviews. Whether you missed our in-depth testing of Sony’s latest flagship earbuds or a truly unique ASUS laptop, I’ve compiled our ...

Sony has unveiled its latest in-ear headphones, with the promise of outstanding sound quality and better call quality.

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Executive Editor David Carnoy ...

Our hands-on review of Sony’s new top-of-the-line WF-1000XM6 wireless earbuds reveals they’ve been improved in a few key areas. It wasn’t that long ago that wireless earphones were a punchline. “Truly ...

Christian de Looper is a freelance consumer tech reporter based in sunny Santa Cruz, California. With a Bachelor's Degree in Music Technology, Christian leverages his industry knowledge to review ...

The new flagship earbuds are the best at ANC, if you can get a good seal in your ear. If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. is a senior ...

Menace Early Access Video Review Menace reviewed in Early Access by Leana Hafer on PC. Menace is off to more than a running start already. The turn-based tactical action is some of the best I've ...

INMO Air 3 smart AR glasses offer a 150-inch virtual screen with 600 nits brightness, 1.5–2 hours per charge and 1-hour full ...

This business development company/BDC specializes in growth capital primarily in the USA for middle-market companies. It is headquartered in LA, CA, and was founded in 2004. It has a BBB S&P credit ...

Pfizer (PFE) announced on Friday that the U.S. Food and Drug Administration granted priority review for a marketing application seeking a label expansion for its hemophilia therapy, Hympavzi. The New ...